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INTRODUCTION
 Cancer is one of the leading causes of death 
in the world. In 2015, around 8.2 million deaths 
were caused by cancer, one of which was cervical 
cancer. According to data center and information 
(INFODATIN, 2015),  cervical  cancer  has  the 
second highest percentage of new cases experienced 
by women in the world by 14% (INFODATIN, 
2015). Several treatments have been made to reduce 
mortality due to this disease, one of them is by the use 
of cisplatin, a chemotherapy drug. However, the use 
of cisplatin is limited because of drug resistance and 
many side effects (Sihotang, 2008). Combination 
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Abstract
  
 As one of the leading causes of death in worldwide, cervical cancer requires the effective 
therapies to reduce its mortality rate. One of the chemotherapy agents that frequently used 
in the treatment is cisplatin. However, due to drug resistance and its side effects, an agent 
that can be combined with cisplatin is needed. Parijoto fruit (Medinilla speciosa Reinw.ex.Bl) 
contains  secondary metabolites compounds that have potential as anticancer. The study aims 
to determine the cytotoxic effect of methanol extract of Parijoto fruit calculated from the 
IC50 value and the synergicity of the combinational treatment with cisplatin evaluated from 
the Combination Index (CI) value and its cell viability by using MTT assay. Results showed that 
methanol extract of Parijoto fruit (MEP) performed cytotoxic effect on HeLa cell line with IC50 
of 209.6 μg/mL while the value of IC50 of cisplatin against HeLa cells amounted to 12.8 μg/
mL. The combination of 26.205 ppm (1/8 IC50) of MEP and 1.601 ppm (1/8 IC50) of Cisplatin 
performed synergistic effect on HeLa cell line with the CI value of 0.69. From the above 
results, it can be concluded that MEP is potential as co-chemotherapy agent based on the 
synergistic cytotoxicity effect with cisplatin.
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therapy is the right choice to overcome the 
limitations of cisplatin use and natural ingredients 
can be used as its co-chemotherapy agents. 
 One of the natural ingredient has potential 
to be explored is Parijoto fruit (Medinilla speciosa 
Reinw.ex.Bl). It contains secondary metabolites in 
the form of flavonoids, alkaloids, tannins, saponins, 
glycosides and terpenoids (Vifta, et al., 2018). 
 17
Indonesian Journal of Cancer Chemoprevention, February 2020
ISSN: 2088–0197
e-ISSN: 2355-8989
Some in vitro studies show that these metabolites 
have anticancer activity. In a previous study it was 
reported that the ethanolic extract of Parijoto fruit 
has a cytotoxic effect on T47D breast cancer cells 
with an IC50 value of  614.50 μg/mL (Tussanti, et 
al., 2014). This study will examine the cytotoxic 
effect of the methanol extract of Parijoto fruit 
(MEP) and its combination treatment with Cisplatin 
against cervical cancer using the HeLa cell line. The 
treatment will be compared with vero cell line, asa 
normal cell model. This combination is expected 
to provide a synergistic effect in increasing the 
sensitivity of the chemotherapy agent and reducing 
the toxicity arising from cisplatin. The cytotoxic 
effect of MEP was calculated from the IC50 value 
and the synergy of its combination with cisplatin 





 Parijoto fruits (Medinilla speciosa, Reinw.
ex Bl.) were taken from the Muria Mountain Area, 
Colo Village, Dawe District, Kudus Regency, 
Central Java, Indonesia. Plants were identified at the 
Biology Laboratory of Faculty of Math and Science, 
UNS. Cisplatin (Kalbe, Jakarta, Indonesia) was 
obtained from the Dr. Moewardi District Hospital, 
Surakarta. HeLa cell and Vero cell are obtained 
from the collection of Cancer Chemoprevention 
Research Center (CCRC) Faculty of Pharmacy, 
Universitas Gadjah Mada. 
Cell Culture
 Roswell Park Memorial Institute (RPMI) 
1640 (Gibco, New York, USA) media containing 
Foetal Bovine Serum (FBS) 10% (v/v) (Gibco), 
penicillin streptomycin 1% (v/v) (Gibco) was used. 
Trypsin-EDTA in concentration of 0.25% was used 
to harvest the adherent cells. Dimethyl sulfoxide 
(DMSO) (Sigma Aldrich, Missouri, USA) was used 
to dissolve the extract. The 3-(4,5-dimethyltiazol-
2-il)-2,5 diphenyltetrazolium bromide (MTT) 
(Sigma) was used for MTT assay. The stopper used 
was sodium dodecyl sulfate (SDS) 10% (Merck, 
Frankfurt, Germany) in 0.01 N HCl (Merck).
Sampel Preparation
 Parijoto fruit was macerated with 500 mL 
methanol (Brataco, Cikarang, Indonesia) for 2x24 
h. It continued by re-macerated with three equal 
solvents of 200 mL per each for 24 h. The macerate 
is collected and evaporated with a rotary evaporator 
at a temperature of 5000C andre-concentrated by 
heating it over a water bath until a viscous extract is 
obtained.
Cytotoxic MTT Assay
 MEP were dissolved in DMSO and was 
made a series of concentrations between 30-240 μg/
mL  for cytotoxic tests of HeLa cells. Cytotoxic tests 
on vero cells were made in series of concentrations 
of 7.81; 15.63; 31.25; 62.5; 125; 250; 500; 1000 μg/
mL. The concentration of the cisplatin test solution 
was made in series of concentrations between 1-20 
μg/mL. HeLa cells (10x103/well) were cultured to 
96 well-plates in RPMI media, then incubated at 
370C for 24 h. Then, MEP and cisplatin were added 
in DMSO, incubated in a 5% CO2 incubator for 24 
h. MTT solution (0.5 mg/mL in 100 μL of culture 
media) was added to each well, incubated for 4 h at 
370C. A 10% SDS stopper in 0.01 N HCl was added 
and incubated at room temperature for 24 h and 
protected by light. Thus absorbance measurements 
is conducted with enzyme-linked immunosorbent 
assay (ELISA) reader at a wavelength of 595 nm. 
The data obtained is in the form of absorbance 
which is converted into percent of living cells. 
Formula for living cells:
(sample absorbantion-medium absorbantion)/
(control absorbantion-medium absorbantion)x100%
 The results of cell viability versus sample 
concentration are graphed linear regression 
equations to obtain the function equation y=bx+a 
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then the IC50 value is obtained. Based on the 
IC50 value of the single cytotoxic test, the series 
concentration was made as much as 1/2 IC50, 1/4 
IC50,1/8 IC50 both the MEP and cisplatin, To evaluate 
the synergism of a combination using equation:
Combination Index= (D)1/(Dx)1+(D)2/(Dx)2 
Dx1 and Dx2 are concentrations of  one  single 
compound needed to exert an effect (IC50 on 
the growth of HeLa cells), D1 and D2 are the 
concentrations of the two compounds to give the 
same effect. The results of the CI obtained are then 
interpreted according to Table 1.
Index Selectivity Test
 To examine whether the extract is 
safe against normal cells, the selectivity index 
analysis was performed using the formula: 
Selectivity index=(IC50 vero cell line)/(IC50 cancer 
cell line)
Table 2 shows the interpretations of index selectivity.
Ethics Approval
 This study was approved by the Research 
Ethics Commission of the Faculty of  Medicine, 
Universitas Muhammadiyah Surakarta (FK UMS) 
proven through Ethical clearance approval number: 
1814/A.1/KEPK-FKUMS/I/2019.
RESULT 
Cytotoxicity Effect of MEP on HeLa Cells
 MEP is obtained with a weight of 20.2 grams 
with red extract color and a yield of 4.05%. The 
cytotoxic effect test on HeLa cells is a preliminary 
test using the MTT assay method whose absorption 
results will give a purple color and the absorbance 
measured with the ELISA reader. The absorbance 
results are used to calculate the IC50 value, which 
is the ability of a compound that can cause growth 
inhibition in 50% of the cell population. IC50 values 
of MEP obtained in the treatment of 209.6±3.55 μg/
mL. While the IC50 value of cisplatin in HeLa cells 
was 12.08±1.06 μg/mL. The percentage of viability 
results are presented in Figure 1.
Cytotoxicity Effect of Combination of MEP 
and Cisplatin on HeLa Cells
 Synergistic cytotoxic effects are seen by 
combining MEP with cisplatin. IC50 values of 
MEP and cisplatin were used  as  guidelines  for 
determining  the concentrations.  The  concentration 
variations used were   1/2 IC50, 1/4 IC50, 1/8 IC50. 
The results of the calculation of the CI value can 
be seen in Table 3. The results of the CI show the 
combination of MEP and cisplatin is synergistic 
with a combination of 26.205 ppm (1/8 IC50) of 
MEP+1.601 ppm (1/8 IC50) of cisplatin with a 
percentage of cell viability of 80.58 %.
Table 1. Interpretations of CI
Table 2. Interpretations of Index Selectivity
Combination Index Interpretation
 
<0.1  Very strong sinergistic 
0.1–0.3 Strong sinergistic





1.1–1.45  Moderate Antagonist
 
1.45–3.3  Antagonist 
>3.3  Strong Antagonist
 
Index Selectivity Interpretation  
Selectivity index >=3 Selective 
Selectivity index <3 Non Selective 
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Figure 1. Cytotoxicity effect of MEP against HeLa cells. Cells were seeded in 96 well plates with a density of 10x103/
well and incubated for 24 h. Cells were treated with MEP in concentration series of 30 µg/mL; 60 µg/mL; 120 
µg/mL; 210 µg/mL; 240 µg/mL. Cells viability were obtained from the conversion of absorbance values by MTT 
treatment as described in the method. Data are representative of values from three independent experiment. 





1.601  3.202  6.405 
26.205 0.69  1 .83 1.79 
52.41 1.00  2 .75 1.80
 
104.82 0.93  1.19 1.09
 
 
Tabel 3. Synergistic cytotoxic effects are seen by combining MEP with cisplatin
DISCUSSION
 This study aims to determine the cytotoxic 
effect of MEP that can be seen from the IC50 
parameters and the synergy of its combination with 
cisplatin against HeLa cervical cancer cells in terms 
of its CI value parameters. The yield analysis shows 
that the methanol solvent has a high percentage of 
yield (20.2 grams). These results indicate that the 
methanol solvent has a higher ability to extract the 
active component of the Parijoto fruit. The high 
percentage of yield in methanol solvents is thought 
to be due to the large content of polar phytochemical 
compounds in Parijoto fruit. Parijoto fruit has been 
shown to contain flavonoid compounds with groups 
similar to flavonol compounds (Vifta, et al., 2018). 
These results are strengthened by qualitative TLC 
test data previously carried out, namely methanol 
extract of positive parijoto fruits containing 
secondary metabolite compounds of quercetin 
(Unpublish data, 2019). The total presence of this 
compound is thought to be one of the influences 
in cytotoxic effects of Parijoto fruit extracts. 
 The results of a single cytotoxic test of 
the MEP showed that the extracts had a moderate 
cytotoxic effect on HeLa cells. A compound that has 
an IC50 value of less than 100 μg/mL is a compound 
with a potential cytotoxic effect, a compound that 
has an IC50 value of 100-1000 μg/mL can be said 
to be a compound with a moderate cytotoxic effect. 
The compound has no cytotoxic effect if the IC50 
value more than 1000 μg/mL (Prayong, et al., 
2008). The MEP has the highest cytotoxic effect 
on HeLa cells seen from the lowest IC50 parameter. 
The high cytotoxic effect on MEP is probably due 
to the fact that the methanol solvent dissolves more 
polar secondary metabolites such as quercetin. In a 
cytotoxic test the combination of synergistic activity 
from the combination of MEP (26.205 ppm or 1/8 
IC50) and cisplatin (1.601 ppm or 1/8 IC50)  is likely to 
result from the same action target or different action 
target in inducing cell apoptosis. The mechanism of 
cell apoptosis is thought to involve components of 
secondary metabolites contained in Parijoto fruit.
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Table 4. Results of Index Selectivity values.
Treatment IC50 value treatment 
/mL)  
IC50 value treatment 




MEP 209.64  52.58  25.08  Selective 




Figure 2. Effect of MEP in combination with cisplatin on HeLa cel viability. Cells with density of 10x103/well were 
seeded on 96 well plates. Morphology and cytotoxic effects of HeLa cells after 24 h treatment. a: combination 
of MEP 26.205 ppm (1/8 IC50) and cisplatin 1.601 ppm (1/8 IC 50), b: combination of MEP 104.82 μg/mL (1/2 
IC50)  and cisplatin 6.405 μg/mL (1/2 IC50), c: single cisplatin 12.81 μg/mL (1 IC50), d: control or untreated 
cells.  The black arrow (             ) indicates living cells, meanwhile the doted  arrow (                ) indicates dead cells.
This is reinforced by the presence of quercetin in 
the methanol extract of Parijoto fruit. Quercetin 
triggers apoptosis in cancer cells by inducing 
p53 protein expression and involves modulation 
of cell cycle regulating proteins, activating the B 
cell lymphoma-2 (Bcl-2) (Siegelin, et al., 2008). 
This activation will cause inhibition of signal 
transduction from growth factors which will 
then induce  cell  apoptosis (Wickremasinghe, et 
al., 1999). Quercetin can also inhibit HeLa cell 
proliferation through cell cycle arrest in the G2/M 
phase. While the mechanism of action of cisplatin 
via the intrinsic pathway causes damage to the DNA 
of cancer cells regulated by the Bcl-2 protein. This 
DNA damage results in the release of cytochrome 
C from the mitochondria, thereby activating 
procaspase 9 through the interaction of apoptosis 
promoting activating factor-1 (APAF-1) and active 
apoptosome formation (Dasari, et al., 2014). 
 The value of CI in the treatment of high 
cisplatin concentrations tends to approach the 
additive effect to the antagonist this is due to the 
cisplatin mechanism that experiences resistance in 
cells. Cell resistance causes cisplatin to not damage 
cell DNA so that p53 protein cannot be activated. 
Activation of p53 protein will trigger programmed 
cell death (cell apoptosis). Failure to activate the p53 
protein will cause an uncontrolled proliferation of 
cancer cells. Therefore the existence of a combination 
of a natural compound with chemotherapy drugs 
is expected to reduce resistance in cancer cells 
and increase the occurrence of apoptosis  in  the 
development of cancer therapy (Mutiah, 2014). 
Based on Table 4, MEP is categorized as having 
high selectivity while cisplatin as a positive control 
is categorized as not selective. A compound can be 
categorized selectively if it has a Selectivity index 
value ≥3 and categorized as not selective if the 
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Selectivity index value less than 3. A compound 
that has cytotoxic activity and has a high selectivity 
can be developed into a chemopreventive agent 
because it can distinguish between cancer cells 
and normal cells from the needs of Adenosine 
Triphospat (ATP) of these cells. Cancer cells will 
require large ATP energy to replicate quickly and 
actively. Chemopreventive agents work to block 
energy production by attaching to the mitochondria 
of cancer cells.
   
CONCLUSION
 In a single treatment, MEP has cytotoxic 
effect againts HeLa cell with the IC50 values of 209.6 
μg/mL and in the combinational treatment with 
cisplatin, it showed theis synergistic effect with CI 
value of 0.69. Based on this study, MEP is potential 
co-chemotherapy agent based on the synergistic 
cytotoxicity effect with cisplatin, particularly in 
the cervical cancer treatment. To strengthen this 
conclusion, the further study should be conducted.
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